• Corpus ID: 17070955


  author={Ronald T. Brown and Robert William Amler and Wendy S. Freeman and James M. Perrin and Martin T. Stein and Heidi M. Feldman and Karen L. Pierce and Mark L. Wolraich},
The American Academy of Pediatrics’ Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder, reviewed and analyzed the current literature for the purpose of developing an evidence-based clinical practice guideline for the treatment of the school-aged child with attentiondeficit/hyperactivity disorder (ADHD). This review included several key reports, including an evidence review from the McMaster Evidence-Based Practice Center (supported by the Agency for… 



Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

This guideline, the second in a set of policies on this condition, is intended for use by clinicians working in primary care settings and contains the following recommendations for the treatment of a child diagnosed with ADHD.

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.

  • P. JensenL. Kettle J. Payne
  • Psychology, Medicine
    Journal of the American Academy of Child and Adolescent Psychiatry
  • 1999
Medication treatments are often not used in treating ADHD children identified in the community, suggesting the need for better education of parents, physicians, and mental health professionals about the effectiveness of these treatments.

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.

Three clinical profiles are indicated, ADHD co-occurring with internalizing disorders (principally parent-reported anxiety disorders) absent any concurrent disruptive disorder (ADHD + ANX), ADHD Co-occurred with ODD/CD but no anxiety (AD HD + ODD /CD), and ADHD with both anxiety and O DD/CD may be sufficiently distinct to warrant classification as ADHD subtypes different from "pure" ADHD with neither comorbidity.

Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.

A composite of ADHD variables may be an important tool in future treatment trials with ADHD and may avoid some of the statistical limitations of multiple measures.

Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder.

Methylphenidate has short-term positive effects on children and adolescents with CD and key aspects of antisocial adjustment appear to be treatment responsive, independent of severity of the children's initial ADHD symptoms.

Anxiety as a Predictor and Outcome Variable in the Multimodal Treatment Study of Children with ADHD (MTA)

Initial moderator analyses in the Multimodal Treatment Study of Children with ADHD (MTA) suggested that child anxiety ascertained by parent report on the Diagnostic Interview Schedule for Children

Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.

It is suggested that integrated studies evaluate multiple dimensions of functioning and in novel settings (e.g., home, school) and the incorporation of other intervention components in combined treatments may be warranted to enhance clinical efficacy.

Effects of a school-based cognitive-behavioral intervention for ADHD children

It was concluded that the intervention had minimal short-term effects on the ADHD children and two variations of school-based cognitive-behavioral training program were compared to each other and to a waiting-list control condition.

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

Previous retrospective results indicating that children with ADHD are at high risk of developing a wide range of impairments affecting multiple domains of psychopathology such as cognition, interpersonal, school, and family functioning are confirmed.

Behavioral versus Behavioral and Pharmacological Treatment in ADHD Children Attending a Summer Treatment Program

Comparisons to normative data revealed that Comb children were more likely to fall within the normative range on 6 measures, and the differences between these results and the main MTA results, in which Comb was always superior to Beh are discussed in terms of the relative intensity of combined treatments.